SIG | Dietary Therapies for Epilepsy: Safety, Efficacy, and Recommendations for Keto Therapy in Special Populations

Tuesday, December 8, 2026 at 7:00 AM to 8:30 AM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

As an increase in ketogenic diet program centers expands access to care, diet starts in the infant population and in emergent cases increases. Does the data indicate safety in and efficacy of ketogenic therapy implementation in the following special populations: those suffering from FIRES and patients in the neonatal ICU? This session features an overview of diagnosis and treatment recommendations for KDT for FIRES, and separately for patients in the NICU, and recommendations for diet implementation and management in these two populations. The session concludes with questions from the audience and answers provided by our panel of experts.
Learning Objective 1
Apply current knowledge regarding the efficacy and safety of the ketogenic diet in treatment of FIRES
Learning Objective 2
Apply current knowledge regarding the efficacy and safety of the ketogenic diet in treating appropriate patients who are in the neonatal ICU
Learning Objective 3
Describe recommended guidelines for implementing the ketogenic diet in patients who suffer from FIRES or are patients in the neonatal ICU
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsFirst-time Attendee
Session Content Includes
Pediatric
Session ID
DIETARYSIG26
Presentation Id
3452231
Event ID
24056
Session Type
Session